The JAK/STAT and PI3K/AKT signaling pathways appear not to be influenced by the ENO3 states within HCC cells, as phosphorylated AKT and phosphorylated STAT3 levels failed to vary when ENO3 was upregulated or downregulated. The gene discussed is STAT3; the disease is hepatocellular carcinoma.